Pathogen-specific structural features of

Humans Candida albicans Antifungal Agents / pharmacology Candidiasis / microbiology Signal Transduction Guanine Nucleotide Exchange Factors / metabolism Fungal Proteins / genetics Hyphae
Ras-like protein 1 X-ray crystallography cell division control protein 25 polyQ small angle X-ray scattering

Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
31 08 2023
Historique:
medline: 4 9 2023
pubmed: 1 8 2023
entrez: 1 8 2023
Statut: ppublish

Résumé

An important feature associated with

Identifiants

DOI: 10.1128/mbio.00638-23 PMID: 37526476 PMC: PMC10470544
pubmed: 37526476
doi: 10.1128/mbio.00638-23
pmc: PMC10470544
doi:

Substances chimiques

Antifungal Agents 0
Guanine Nucleotide Exchange Factors 0
Fungal Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0063823

Déclaration de conflit d'intérêts

A patent application entitled "Pathogen-specific peptide to block virulence-related signalling in

Références

Nucleic Acids Res. 2016 Jul 8;44(W1):W344-50
pubmed: 27166375
Science. 1993 May 28;260(5112):1338-43
pubmed: 8493579
Nucleic Acids Res. 2008 Jan;36(Database issue):D557-61
pubmed: 18039716
Bioinformatics. 2013 Jan 1;29(1):69-76
pubmed: 23129295
J Struct Biol. 2016 Feb;193(2):106-14
pubmed: 26687416
Cell. 2010 Dec 23;143(7):1121-35
pubmed: 21183075
Nucleic Acids Res. 2015 Jan;43(Database issue):D357-63
pubmed: 25352555
Infect Immun. 2014 Feb;82(2):532-43
pubmed: 24478069
Cold Spring Harb Perspect Med. 2014 Sep 02;4(9):a019778
pubmed: 25183855
Mol Microbiol. 2017 Mar;103(5):764-779
pubmed: 27888610
Mol Microbiol. 2000 Oct;38(2):348-58
pubmed: 11069660
Protein Sci. 2020 Jan;29(1):128-140
pubmed: 31606894
PLoS One. 2012;7(11):e49932
pubmed: 23189173
Nat Commun. 2016 Mar 07;7:10882
pubmed: 26947396
Trends Biochem Sci. 2017 Jun;42(6):410-412
pubmed: 28487210
J Mol Biol. 2013 Aug 9;425(15):2782-94
pubmed: 23659792
Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):E6766-E6775
pubmed: 27791178
Front Neurol. 2013 Jun 20;4:76
pubmed: 23801983
Pathogens. 2019 Apr 22;8(2):
pubmed: 31013590
Nucleic Acids Res. 2012 May;40(10):4273-87
pubmed: 22287626
Nat Rev Chem. 2020 Aug;4(8):420-434
pubmed: 37127972
Science. 1990 May 18;248(4957):866-8
pubmed: 2188363
J Am Chem Soc. 2007 May 2;129(17):5656-64
pubmed: 17411046
Elife. 2013 Jul 30;2:e00813
pubmed: 23908768
Proc Natl Acad Sci U S A. 2012 Sep 25;109(39):15781-6
pubmed: 22955885
Hum Mol Genet. 2014 Jul 1;23(13):3402-20
pubmed: 24497578
Antonie Van Leeuwenhoek. 2009 Nov;96(4):395-404
pubmed: 19484503
Nucleic Acids Res. 2021 Jan 8;49(D1):D361-D367
pubmed: 33237329
Cell. 1997 Sep 5;90(5):939-49
pubmed: 9298905
Sci Signal. 2020 Sep 01;13(647):
pubmed: 32873726
Nucleic Acids Res. 2022 Jan 7;50(D1):D439-D444
pubmed: 34791371
J Biol Chem. 1992 Feb 5;267(4):2664-70
pubmed: 1733963
Curr Opin Microbiol. 2015 Aug;26:102-8
pubmed: 26189047
Eukaryot Cell. 2011 Nov;10(11):1473-84
pubmed: 21908593
Mol Biol Cell. 2005 Apr;16(4):1971-86
pubmed: 15673611
mSphere. 2016 Nov 30;1(6):
pubmed: 27921081
Biol Chem. 2019 Dec 18;401(1):143-163
pubmed: 31600136
J Infect Dis. 1993 May;167(5):1247-51
pubmed: 8486965
Cell. 2003 Mar 7;112(5):685-95
pubmed: 12628188
FEMS Yeast Res. 2016 Sep;16(6):
pubmed: 27493146
J Biol Chem. 2016 Sep 2;291(36):18643-62
pubmed: 27413182
J Appl Crystallogr. 2021 Feb 01;54(Pt 1):343-355
pubmed: 33833657
Curr Opin Microbiol. 1998 Dec;1(6):687-92
pubmed: 10066539
Mol Microbiol. 2006 Jul;61(2):484-96
pubmed: 16856944
Mol Cell Biol. 1993 Mar;13(3):1345-52
pubmed: 8441380
BMC Evol Biol. 2020 May 24;20(1):59
pubmed: 32448113
Mol Microbiol. 2013 Jul;89(1):166-78
pubmed: 23692372
Proc Natl Acad Sci U S A. 2006 Nov 7;103(45):16692-7
pubmed: 17075039
Cell. 2007 Jun 1;129(5):865-77
pubmed: 17540168
Curr Opin Struct Biol. 2023 Jun;80:102607
pubmed: 37178477
Curr Protein Pept Sci. 2012 Feb;13(1):55-75
pubmed: 22044150
PLoS One. 2017 Jun 29;12(6):e0180246
pubmed: 28662107
Microb Cell. 2017 Dec 18;5(2):63-73
pubmed: 29417055
Mol Microbiol. 2001 Nov;42(3):673-87
pubmed: 11722734
PLoS One. 2014 Sep 22;9(9):e107457
pubmed: 25243668
Nature. 1998 Jul 23;394(6691):337-43
pubmed: 9690470
J Biol Chem. 2020 Oct 16;295(42):14458-14472
pubmed: 32796038
PLoS Pathog. 2015 Aug 28;11(8):e1005133
pubmed: 26317337
Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3430-5
pubmed: 20133692
Methods Enzymol. 2006;407:159-73
pubmed: 16757322
J Exp Biol. 2014 Jan 1;217(Pt 1):144-55
pubmed: 24353214
Nat Struct Mol Biol. 2023 Mar;30(3):309-320
pubmed: 36864173

Auteurs

José A Manso (JA)

IBMC-Instituto de Biologia Molecular e Celular, Universidade do Porto , Porto, Portugal.
i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto , Porto, Portugal.
ORCID: 0000-0002-2565-6239

Arturo Carabias (A)

Instituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas-University of Salamanca , Salamanca, Spain.
ORCID: 0000-0001-6286-2309

Zsuzsa Sárkány (Z)

IBMC-Instituto de Biologia Molecular e Celular, Universidade do Porto , Porto, Portugal.
i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto , Porto, Portugal.
ORCID: 0000-0001-9185-8210

José M de Pereda (JM)

Instituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas-University of Salamanca , Salamanca, Spain.
ORCID: 0000-0002-8912-6739

Pedro José Barbosa Pereira (PJB)

IBMC-Instituto de Biologia Molecular e Celular, Universidade do Porto , Porto, Portugal.
i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto , Porto, Portugal.
ORCID: 0000-0003-0969-5438

Sandra Macedo-Ribeiro (S)

IBMC-Instituto de Biologia Molecular e Celular, Universidade do Porto , Porto, Portugal.
i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto , Porto, Portugal.
ORCID: 0000-0002-7698-1170

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Pathogen-specific structural features of
questionsmedicales.fr › Eucaryotes › Champignons › Levures › Candida › Candida albicans › Pathogen-specific structural features of
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antifongiques › Pathogen-specific structural features of
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Mycoses › Candidose › Pathogen-specific structural features of
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Transduction du signal › Pathogen-specific structural features of
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines et peptides de signalisation intracellulaire › Régulateurs des protéines G › Facteurs d'échange de nucléotides guanyliques › Pathogen-specific structural features of
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines fongiques › Pathogen-specific structural features of
questionsmedicales.fr › Structures fongiques › Mycelium › Hyphae › Pathogen-specific structural features of